drugset / Trial / NCT04305184
A Study to Assess ASP0598 Otic Solution Following Topical Application in the Ear in Subjects With Chronic Tympanic Membrane Perforation (CTMP)
RandomizedSequentialDouble-blindTreatment
Summary
The primary purpose of this study was to evaluate the safety and tolerability of ASP0598 Otic Solution. This study also evaluated the efficacy of ASP0598 otic solution.
Timeline
- Start
- 2020-09-10
- Primary completion
- 2023-01-24
- Completion
- 2023-01-24
Outcome
Outcome not reported
Stopped: “Lack of Efficacy”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP0598 | Unknown | 0.03 ug | Other |
| Subject | ASP0598 | Unknown | 0.15 ug | Other |
| Subject | ASP0598 | Unknown | 0.75 ug | Other |
| Subject | ASP0598 | Unknown | 2.25 ug | Other |